Tumor necrosis factor‐α overproduction in Fanconi's anemia

American Journal of Hematology

Volumn 42, Issue 2, 1993, Pages 196-201

  Schultz, John C ^a   Shahidi, Nasrollah T ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

hematopoietic suppression; interferon ; TNF

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FANCONI ANEMIA; FEMALE; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BONE MARROW; CHILD; CHILD, PRESCHOOL; COMPARATIVE STUDY; FANCONI ANEMIA; FEMALE; HUMAN; INTERFERON TYPE II; MALE; MONOCYTES; PHYTOHEMAGGLUTININS; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0027513715     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.2830420211     Document Type: Article

References (44)

1. Formal genetics of Fanconi's anemia
2. Spontane Chromosomenaber‐rationen bei familiärer Panmyelopathie
3. Cross‐link repair in human cells and its possible defect in Fanconi's anemia cells
4. Effects of oxidants and antioxidants on chromosome breaks in Fanconi's anemia
5. Decreased superoxide dismutase activity of erythrocytes and leukocytes in Fanconi's anemia
6. Erythrocyte superoxide dismutase deficiency in Fanconi's anaemia established by two independent methods of assay
7. Increased rate of superoxide ion generation in Fanconi anemia erythrocytes
8. Effect of superoxide dismutase and catalase on spontaneously occurring chromosome breaks in patients with Fanconi's anemia
9. Bovine superoxide dismutase in Fanconi anemia. Therapeutic trial in two patients
10. Protection of bone marrow progenitor cells by superoxide dismutase
11. Suppression of cytotoxic effect of mitomycin‐C by superoxide dismutase in Fanconi's anemia and dyskeratosis congenita fibroblasts
12. Tumor necrosis factor and CD11/CD18 (β2) integrins act synergistically to lower cAMP in human neutrophils
13. Gamma interferon is able to enhance the oxidative metabolism of human neutrophils
14. Immune interferon enhances functional properties of human granulocytes: Role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte‐macrophage colony‐stimulating factor
15. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes
16. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo
17. Gamma interferon and aplastic anemia
18. Flow cytometry analysis and gamma interferon production of peripheral blood mononuclear cells in aplastic anemia
19. Further evidence for lymphokine overproduction in severe aplastic anemia
20. In vitro interferon‐gamma production by cultured T‐cells in severe aplastic anemia: Correlation with granulomonopoietic inhibition in patients who respond to anti‐thymocyte globulin
21. Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes
22. Establishment of an interleukin 2‐dependent T cell line derived from a patient with severe aplastic anemia, which inhibits in vitro hematopoiesis
23. Comparative analysis of the influences of human gamma, alpha, and beta interferons on human multipotential (CFU‐GEMM), erythroid (BFU‐E) and granulocyte‐macrophage (CFU‐GM) progenitor cells
24. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of tumor necrosis factor and interferon‐γ
25. γ interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation
26. γ‐Interferon in aplastic anemia: Inability to detect significant levels in sera or demonstrate hematopoietic suppressing activity
27. No evidence for gamma‐interferon mediated haematopoietic inhibition by T cells in aplastic anemia: An observation in the course of immunosuppressive therapy
28. Natural killer (NK) cell‐derived hematopoietic colony‐inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon
29. Tumor necrosis factor and human hematopoiesis: I. Kinetics and diversity of human bone marrow cell response to recombinant tumor necrosis factor alpha in shortterm suspension cultures in vivo
30. Synergistic inhibition of human marrow granulocyte‐macrophage progenitor cells by prostaglandin E and recombinant interferon‐α, ‐β, and ‐γ and an effect mediated by tumor necrosis factor
31. Antileukemic effect of recombinant tumor necrosis factor α in vitro and its modulation by α and γ interferons
32. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia‐derived granulocyte‐macrophage progenitor cells
33. Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells
34. Inhibition of human colony‐forming‐unit erythroid by tumor necrosis factor requires accessory cells
35. Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice
36. Phase 1 study of recombinant tumor necrosis factor in cancer patients
37. Effects on leukocytes after injection of tumor necrosis factor into healthy humans
38. Lymphokine overproduction in severe aplastic anemia is not related to blood transfusions
39. Increased production of tumor necrosis factor‐α by peripheral blood mononuclear cells in the patients with aplastic anemia
40. Analysis at the clonal level of T‐cell phenotype and functions in severe aplastic anemia patients
41. The pathophysiology of aplastic anemia
42. Tumor necrosis factor and reactive oxygen species: Implication for free radical‐induced tissue injury
43. Acceleration of superoxide production from leukocytes in trauma patients
44. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor